These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 1422216)
21. Increased cellular uptake of the human immunodeficiency virus-1 Tat protein after modification with biotin. Chen LL; Frankel AD; Harder JL; Fawell S; Barsoum J; Pepinsky B Anal Biochem; 1995 May; 227(1):168-75. PubMed ID: 7668378 [TBL] [Abstract][Full Text] [Related]
22. A fast method for obtaining highly pure recombinant herpes simplex virus type 1 thymidine kinase. Fetzer J; Michael M; Bohner T; Hofbauer R; Folkers G Protein Expr Purif; 1994 Oct; 5(5):432-41. PubMed ID: 7827501 [TBL] [Abstract][Full Text] [Related]
23. Codelivery to mammalian cells of a transcriptional factor with cis-acting element using cationic liposomes. Farhood H; Gao X; Barsoum J; Huang L Anal Biochem; 1995 Feb; 225(1):89-93. PubMed ID: 7778790 [TBL] [Abstract][Full Text] [Related]
24. High-level expression and purification of Tat-haFGF19-154. Huang Y; Rao Y; Feng C; Li Y; Wu X; Su Z; Xiao J; Xiao Y; Feng W; Li X Appl Microbiol Biotechnol; 2008 Jan; 77(5):1015-22. PubMed ID: 18000664 [TBL] [Abstract][Full Text] [Related]
25. Bacterial production and purification of recombinant human prolactin. Paris N; Rentier-Delrue F; Defontaine A; Goffin V; Lebrun JJ; Mercier L; Martial JA Biotechnol Appl Biochem; 1990 Aug; 12(4):436-49. PubMed ID: 2169258 [TBL] [Abstract][Full Text] [Related]
26. Functional analysis of the N-terminal domain of Tat protein of the human immunodeficiency virus type 1. Reddy MV; Desai M; Jeyapaul J; Prasad DD; Seshamma T; Palmeri D; Khan SA Oncogene; 1992 Sep; 7(9):1743-8. PubMed ID: 1501886 [TBL] [Abstract][Full Text] [Related]
27. A new approach on the purification of recombinant human soluble catechol-O-methyltransferase from an Escherichia coli extract using hydrophobic interaction chromatography. Passarinha LA; Bonifácio MJ; Soares-da-Silva P; Queiroz JA J Chromatogr A; 2008 Jan; 1177(2):287-96. PubMed ID: 17588591 [TBL] [Abstract][Full Text] [Related]
28. The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication. Su J; Naghavi MH; Jejcic A; Horal P; Furuta Y; Wu YP; Li SL; Hall WW; Goobar-Larsson L; Svennerholm B; Vahlne A J Hum Virol; 2001; 4(1):8-15. PubMed ID: 11213934 [TBL] [Abstract][Full Text] [Related]
29. Rapid purification of monomer HIV-2 Tat protein expressed in Escherichia coli. Rhim H; Chan F; Echetebu CO; Rice AP Protein Expr Purif; 1993 Feb; 4(1):24-31. PubMed ID: 8425105 [TBL] [Abstract][Full Text] [Related]
31. Expression and purification of recombinant and native calreticulin. Baksh S; Burns K; Busaan J; Michalak M Protein Expr Purif; 1992 Aug; 3(4):322-31. PubMed ID: 1422226 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of the biologically active beta-subunit of human nerve growth factor in Escherichia coli. Negro A; Martini I; Bigon E; Cazzola F; Minozzi C; Skaper SD; Callegaro L Gene; 1992 Jan; 110(2):251-6. PubMed ID: 1537563 [TBL] [Abstract][Full Text] [Related]
33. Assay, purification and characterization of a recombinant malaria circumsporozoite fusion protein by high-performance liquid chromatography. Folena-Wasserman G; Inacker R; Rosenbloom J J Chromatogr; 1987 Dec; 411():345-54. PubMed ID: 3327867 [TBL] [Abstract][Full Text] [Related]
34. Expression and purification of active recombinant platelet factor 4 from a cleavable fusion protein. Myers JA; Gray GS; Peters DJ; Grimaila RJ; Hunt AJ; Maione TE; Mueller WT Protein Expr Purif; 1991; 2(2-3):136-43. PubMed ID: 1821782 [TBL] [Abstract][Full Text] [Related]
35. Rapid, high-throughput purification of HIV-1 integrase using microtiter plate technology. Wang T; John S; Archuleta S; Jonsson CB Protein Expr Purif; 2004 Feb; 33(2):232-7. PubMed ID: 14711511 [TBL] [Abstract][Full Text] [Related]
36. Use of ethanol-eluted hydrophobic interaction chromatography in the purification of serum amyloid A. Smith JW; McDonald TL Protein Expr Purif; 1991; 2(2-3):158-61. PubMed ID: 1821785 [TBL] [Abstract][Full Text] [Related]
38. Purification and structural characterization of recombinant rat gamma-interferon from Escherichia coli. Lai CY; Dharm E; Fujii Y Anal Biochem; 1989 Feb; 176(2):326-9. PubMed ID: 2500869 [TBL] [Abstract][Full Text] [Related]
39. The effect of cell disruption techniques and chaotropic agents on the downstream purification process of mecasermin produced as inclusion body in E. coli. Haddad L; Babaeipour V; Mofid MR Res Pharm Sci; 2015; 10(6):553-61. PubMed ID: 26779275 [TBL] [Abstract][Full Text] [Related]
40. Use of a urea and guanidine-HCl-propanol solvent system to purify a growth inhibitory glycopeptide by high-performance liquid chromatography. Sharifi BG; Bascom CC; Khurana VK; Johnson TC J Chromatogr; 1985 May; 324(1):173-80. PubMed ID: 4008552 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]